Home » HYBRIDON CHANGES NAME TO IDERA PHARMACEUTICALS
HYBRIDON CHANGES NAME TO IDERA PHARMACEUTICALS
Hybridon, Inc. (Amex: HBY) announced today that it
has changed its name to Idera Pharmaceuticals, Inc. (Amex: IDP). Idera common
shares will begin trading under a new American Stock Exchange symbol 'IDP' on
Tuesday, September 13, 2005. The Company's new website is located at http://www.iderapharma.com. (Logo: http://www.newscom.com/cgi-bin/prnh/20050912/NEM028LOGO.) "This
name change signifies a new era for our Company and reflects the significant
progress we have made in the development of targeted immune therapies based
on Toll-like receptors" commented Sudhir Agrawal, D.Phil., President and
CEO of Idera Pharmaceuticals.
PR
Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May